2. Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum, 1996, 39(1): 87-92.
[3]
3. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med, 1992, 116(6): 488-498.
[4]
4. Deniz K, Ozseker HS, Balas S, et al. Intestinal involvement in Wegener’s granulomatosis. J Gastrointestin Liver Dis, 2007, 16(3): 329-331.
[5]
5. Bacon PA. The spectrum of Wegener’s granulomatosis and disease relapse. N Engl J Med, 2005, 352(4): 330-332.
[6]
6. Jose RJ, Dilworth JP, Cleverley J, et al. Wegener’s granulomatosis with multiple pulmonary nodules-diagnostic difficulties. JRSM Short Rep, 2010, 1(4): 34.
[7]
7. Castaner E, Alguersuari A, Gallardo X, et al. When to suspect pulmonary vasculitis: radiologic and clinical clues. Radiographics, 2010, 30(1): 33-53.
10. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum, 1990, 33(8): 1101-1107.
[11]
11. Apostolova M, Shoib M, Nasser S. Multiple pulmonary nodules: a complex case of Wegener’s granulomatosis. Clin Pract, 2013, 3(1): e14.
[12]
12. Lohrmann C, Uhl M, Kotter E, et al. Pulmonary manifestations of wegener granulomatosis: CT findings in 57 patients and a review of the literature. Eur J Radiol, 2005, 53(3): 471-477.
[13]
13. Mlika M, Ayadi-Kaddour A, Marghli A, et al. Pulmonary localization revealing Wegener’s granulomatosis. ScientificWorldJournal, 2010, 10: 806-810.
[14]
14. Stone JH. Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum, 2003, 48(8): 2299-2309.
